Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
Timothy J. Mitchison, Javier Pineda, Jue Shi, et al.
Open Biology (2017) Vol. 7, Iss. 11, pp. 170182-170182
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Linking cellular stress responses to systemic homeostasis
Lorenzo Galluzzi, Takahiro Yamazaki, Guido Kroemer
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 11, pp. 731-745
Open Access | Times Cited: 417
The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death
Christian Zierhut, Norihiro Yamaguchi, María Cristina Gavilanes Paredes, et al.
Cell (2019) Vol. 178, Iss. 2, pp. 302-315.e23
Open Access | Times Cited: 333
The impact of mitotic errors on cell proliferation and tumorigenesis
Michelle S. Levine, Andrew J. Holland
Genes & Development (2018) Vol. 32, Iss. 9-10, pp. 620-638
Open Access | Times Cited: 232
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 228
Old dogs, new trick: classic cancer therapies activate cGAS
Seoyun Yum, Minghao Li, Zhijian J. Chen
Cell Research (2020) Vol. 30, Iss. 8, pp. 639-648
Open Access | Times Cited: 144
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
Kinsie E. Arnst, Souvik Banerjee, Hao Chen, et al.
Medicinal Research Reviews (2019) Vol. 39, Iss. 4, pp. 1398-1426
Open Access | Times Cited: 127
The molecular origins and pathophysiological consequences of micronuclei: New insights into an age-old problem
Xihan Guo, Juan Ni, Ziqing Liang, et al.
Mutation Research/Reviews in Mutation Research (2018) Vol. 779, pp. 1-35
Closed Access | Times Cited: 113
Chromosomally unstable tumor cells specifically require KIF18A for proliferation
Carolyn Marquis, Cindy L. Fonseca, Katelyn J. Queen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 93
Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells
Patrick Flynn, Peter D. Koch, Timothy J. Mitchison
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 48
Open Access | Times Cited: 85
The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels
Abdul Basit, Min-Guk Cho, Eui-Yun Kim, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 4, pp. 643-657
Open Access | Times Cited: 81
The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING–IFN-β pathway
Mariko Takahashi, Chan‐Wang Jerry Lio, Anaamika Campeau, et al.
Nature Immunology (2021) Vol. 22, Iss. 4, pp. 485-496
Open Access | Times Cited: 67
Paclitaxel resistance related to nuclear envelope structural sturdiness
Elizabeth R. Smith, Jing‐Quan Wang, Dong‐Hua Yang, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100881-100881
Closed Access | Times Cited: 50
Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation
Muhammad Bilal Ahmed, Salman Ul Islam, Abdullah A. A. Alghamdi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15765-15765
Open Access | Times Cited: 47
The Second Selectivity of Taxanes to Malignant Cells --- Nuclear Envelope Malleability
Xiang‐Xi Xu, Elizabeth R. Smith
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1051-1053
Open Access | Times Cited: 1
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
Vildan Bozok Çetintaş, Nizar N. Batada
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 59
CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
Talveen S. Purba, Kayumba Ng’andu, Lars Brunken, et al.
EMBO Molecular Medicine (2019) Vol. 11, Iss. 10
Open Access | Times Cited: 55
The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
Laurence Lafanéchère
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases
Jin Kyung Seok, Minhyuk Kim, Han Chang Kang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 6, pp. 500-534
Open Access | Times Cited: 18
Discovery of Novel Isoquinoline Analogues as Dual Tubulin Polymerization/V-ATPase Inhibitors with Immunogenic Cell Death Induction
Jiafu Leng, Yongjun Zhao, Shifang Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 3144-3166
Closed Access | Times Cited: 6
Photoswitchable CENP-E Inhibitor Enabling the Dynamic Control of Chromosome Movement and Mitotic Progression
Noushaba Nusrat Mafy, Kazuya Matsuo, Shota Hiruma, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 4, pp. 1763-1767
Open Access | Times Cited: 50
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment
Angela Flavia Serpico, Roberta Visconti, Domenico Grieco
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 49
Future prospects for mitosis-targeted antitumor therapies
Alfonso Serrano del Valle, Chantal Reina-Ortiz, Andrea Benedi, et al.
Biochemical Pharmacology (2021) Vol. 190, pp. 114655-114655
Open Access | Times Cited: 39
Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours
Florian J. Groelly, Manuela Porru, J. Zimmer, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 3
Open Access | Times Cited: 26
Molecular Link between DNA Damage Response and Microtubule Dynamics
Jeong‐Ki Min
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6986-6986
Open Access | Times Cited: 25
Combination of microtubule targeting agents with other antineoplastics for cancer treatment
Tingting Liang, Lu Lu, Xueting Song, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188777-188777
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top